{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:25:56Z","timestamp":1783225556091,"version":"3.54.6"},"reference-count":75,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.autrev.2012.03.005","type":"journal-article","created":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T02:50:35Z","timestamp":1333248635000},"page":"898-902","source":"Crossref","is-referenced-by-count":31,"title":["Primary biliary cirrhosis and the nuclear pore complex"],"prefix":"10.1016","volume":"11","author":[{"given":"Carolina","family":"Duarte-Rey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Manuel","family":"Anaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard J.","family":"Worman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2012.03.005_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2009.08.009","article-title":"A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis","volume":"34","author":"Agmon-Levin","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.03.005_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.autrev.2011.05.001","article-title":"Therapeutic blockade of TNF in patients with SLE\u2014promising or crazy?","volume":"11","author":"Aringer","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.03.005_bb0015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.autrev.2010.05.020","article-title":"Anti-Ku antibodies: clinical, genetic and diagnostic insights","volume":"9","author":"Belizna","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.03.005_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2011.06.006","article-title":"Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results","volume":"11","author":"Bonaguri","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.03.005_bb0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.autrev.2010.09.005","article-title":"Clinical and laboratory aspects of Ro\/SSA-52 autoantibodies","volume":"10","author":"Defendenti","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.03.005_bb0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jaut.2010.07.007","article-title":"Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes","volume":"35","author":"Lee","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.03.005_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08916930903374741","article-title":"Pathogenic mechanisms in systemic lupus erythematosus","volume":"43","author":"Perl","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2012.03.005_bb0040","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.autrev.2010.05.001","article-title":"Anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: clinical and immunological features: a propos of 40 new cases and review of the literature","volume":"9","author":"Szalat","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.03.005_bb0045","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1172\/JCI105479","article-title":"Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus","volume":"45","author":"Tan","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2012.03.005_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaut.2011.02.001","article-title":"Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus","volume":"36","author":"Ullal","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.03.005_bb0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jaut.2011.03.002","article-title":"Enforced expression of the apoptosis inhibitor Bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism","volume":"37","author":"Wang","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.03.005_bb0060","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/art.21252","article-title":"Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential","volume":"52","author":"Shoenfeld","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.03.005_bb0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.autrev.2008.08.001","article-title":"Predictive, protective, orphan autoantibodies: the example of anti-phospholipid antibodies","volume":"7","author":"Meroni","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.03.005_bb0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1191\/0961203304lu485oa","article-title":"Clinical significance of anti-dsDNA antibody isotypes: IgG\/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis","volume":"13","author":"Forger","year":"2004","journal-title":"Lupus"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2012.03.005_bb0075","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1111\/j.1872-034X.2007.00227.x","article-title":"Nuclear envelope protein autoantigens in primary biliary cirrhosis","volume":"37","author":"Worman","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.autrev.2012.03.005_bb0080","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0085","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cca.2010.12.019","article-title":"Disease-specific autoantibodies in primary biliary cirrhosis","volume":"412","author":"Bogdanos","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2012.03.005_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2007-1007185","article-title":"Nuclear envelope protein autoantibodies in primary biliary cirrhosis","volume":"17","author":"Courvalin","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2012.03.005_bb0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"Antinuclear antibodies specific for primary biliary cirrhosis","volume":"2","author":"Worman","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.03.005_bb0100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00918255","article-title":"Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis","volume":"5","author":"Ruffatti","year":"1985","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0016-5085(90)91246-3","article-title":"Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis","volume":"99","author":"Lassoued","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2012.03.005_bb0110","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-108-6-829","article-title":"Antinuclear autoantibodies specific for lamins. Characterization and clinical significance","volume":"108","author":"Lassoued","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2012.03.005_bb0115","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.1840080438","article-title":"Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis","volume":"8","author":"Lozano","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2012.03.005_bb0120","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.172.3.961","article-title":"Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis","volume":"172","author":"Courvalin","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.03.005_bb0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0896-8411(03)00033-7","article-title":"Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study","volume":"20","author":"Miyachi","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.03.005_bb0130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/CDLI.10.2.329-331.2003","article-title":"Nucleoporin p62 antibodies in a case of mixed connective tissue disease","volume":"10","author":"Kraemer","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/1874312901004010024","article-title":"Nuclear pore protein p62 autoantibodies in systemic lupus erythematosus","volume":"4","author":"Kraemer","year":"2010","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.autrev.2012.03.005_bb0140","doi-asserted-by":"crossref","first-page":"a000539","DOI":"10.1101\/cshperspect.a000539","article-title":"The nuclear envelope","volume":"2","author":"Hetzer","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0145","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1146\/annurev-biochem-060109-151030","article-title":"The structure of the nuclear pore complex","volume":"80","author":"Hoelz","year":"2011","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.autrev.2012.03.005_bb0150","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/MMBR.65.4.570-594.2001","article-title":"Transport into and out of the nucleus","volume":"65","author":"Macara","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.autrev.2012.03.005_bb0155","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cell.2007.11.038","article-title":"Architecture of a coat for the nuclear pore membrane","volume":"131","author":"Hsia","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2012.03.005_bb0160","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nature06405","article-title":"The molecular architecture of the nuclear pore complex","volume":"450","author":"Alber","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2012.03.005_bb0165","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nature06404","article-title":"Determining the architectures of macromolecular assemblies","volume":"450","author":"Alber","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2012.03.005_bb0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1098\/rspb.1950.0047","article-title":"Experimental studies on amphibian oocyte nuclei. I. Investigation of the structure of the nuclear membrane by means of the electron microscope","volume":"137","author":"Callan","year":"1950","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"10.1016\/j.autrev.2012.03.005_bb0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1083\/jcb.6.2.147","article-title":"Further observations on the nuclear envelope of the animal cell","volume":"6","author":"Watson","year":"1959","journal-title":"J Biophys Biochem Cytol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0180","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1083\/jcb.123.4.771","article-title":"Isolation of the yeast nuclear pore complex","volume":"123","author":"Rout","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0185","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1083\/jcb.135.6.1457","article-title":"A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex","volume":"135","author":"Matunis","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0190","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0092-8674(86)90784-1","article-title":"Identification and characterization of a nuclear pore complex protein","volume":"45","author":"Davis","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2012.03.005_bb0195","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1074\/mcp.M900038-MCP200","article-title":"Evidence for a shared nuclear pore complex architecture that is conserved from the last common eukaryotic ancestor","volume":"8","author":"DeGrasse","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.autrev.2012.03.005_bb0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1172\/JCI114696","article-title":"The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore","volume":"86","author":"Courvalin","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2012.03.005_bb0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0016-5085(94)95333-3","article-title":"Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis","volume":"106","author":"Nickowitz","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2012.03.005_bb0210","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1083\/jcb.108.6.2083","article-title":"Primary structure analysis of an integral membrane glycoprotein of the nuclear pore","volume":"108","author":"Wozniak","year":"1989","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0215","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/j.1460-2075.1990.tb08267.x","article-title":"A major glycoprotein of the nuclear pore complex is a membrane-spanning polypeptide with a large lumenal domain and a small cytoplasmic tail","volume":"9","author":"Greber","year":"1990","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2012.03.005_bb0220","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1046\/j.1432-1327.2001.02290.x","article-title":"Biochemical characterization of nuclear pore complex protein gp210 oligomers","volume":"268","author":"Favreau","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.autrev.2012.03.005_bb0225","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1084\/jem.178.6.2237","article-title":"Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210","volume":"178","author":"Nickowitz","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.03.005_bb0230","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1084\/jem.182.4.1159","article-title":"Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210","volume":"182","author":"Wesierska-Gadek","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.03.005_bb0235","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.510230512","article-title":"Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis","volume":"23","author":"Bandin","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2012.03.005_bb0240","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"Itoh","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0245","first-page":"495","article-title":"Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope","volume":"21","author":"Tartakovsky","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2012.03.005_bb0250","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/jaut.1997.0156","article-title":"Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis","volume":"10","author":"Mattalia","year":"1997","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.03.005_bb0255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00351173","article-title":"Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC","volume":"23","author":"Miyachi","year":"1996","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.autrev.2012.03.005_bb0260","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0168-8278(98)80233-X","article-title":"The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis","volume":"28","author":"Luettig","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0265","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2012.03.005_bb0270","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2004.11.016","article-title":"Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis","volume":"42","author":"Nakamura","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0275","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"Liu","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.03.005_bb0280","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","article-title":"Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis","volume":"98","author":"Muratori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0285","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jmb.2007.05.030","article-title":"Domain topology of the p62 complex within the 3-D architecture of the nuclear pore complex","volume":"370","author":"Schwarz-Herion","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0290","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1091\/mbc.6.11.1591","article-title":"Structural analysis of the p62 complex, an assembly of O-linked glycoproteins that localizes near the central gated channel of the nuclear pore complex","volume":"6","author":"Guan","year":"1995","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.autrev.2012.03.005_bb0295","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1101\/sqb.2010.75.059","article-title":"Nuclear pore complexes: guardians of the nuclear genome","volume":"75","author":"Capelson","year":"2010","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0300","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/gast.1996.v110.pm8608894","article-title":"Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis","volume":"110","author":"Wesierska-Gadek","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2012.03.005_bb0305","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1196\/annals.1398.058","article-title":"Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies","volume":"1109","author":"Wesierska-Gadek","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2012.03.005_bb0310","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jcb.21595","article-title":"Characterization of the antibodies to p62 nucleoporin in primary biliary cirrhosis using human recombinant antigen","volume":"104","author":"Wesierska-Gadek","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.autrev.2012.03.005_bb0315","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.2004.02432.x","article-title":"The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence","volume":"136","author":"Ou","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0320","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"Wesierska-Gadek","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2012.03.005_bb0325","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1016\/S0168-8278(09)60678-4","article-title":"Fine specificity of anti-nup62 T-helper 1 cell (TH1) immune responses in priumary biliary cirrhosis","volume":"50","author":"Meda","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0330","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0168-8278(00)00040-4","article-title":"Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis","volume":"34","author":"Invernizzi","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0335","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/hep.21678","article-title":"Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis","volume":"45","author":"Bogdanos","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2012.03.005_bb0340","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.3748\/wjg.v16.i39.4938","article-title":"Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients","volume":"16","author":"Sfakianaki","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0345","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaut.2005.10.007","article-title":"Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis","volume":"26","author":"Nakamura","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.03.005_bb0350","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2012.03.005_bb0355","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(97)05419-6","article-title":"Primary biliary cirrhosis","volume":"350","author":"Neuberger","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2012.03.005_bb0360","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(03)00283-6","article-title":"Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence","volume":"39","author":"Neuberger","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1568-9972(02)00103-9","article-title":"Liver transplantation for primary biliary cirrhosis","volume":"2","author":"Neuberger","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.03.005_bb0370","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-8278(98)80220-1","article-title":"Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation","volume":"28","author":"Dubel","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2012.03.005_bb0375","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0016-5085(03)00387-1","article-title":"Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis","volume":"124","author":"Shimoda","year":"2003","journal-title":"Gastroenterology"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T04:30:21Z","timestamp":1593923421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997212000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":75,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1568997212000742"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2012.03.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}